Insys Therapeutics, Inc. Releases Statement on Payor Interactions
July 17, 2017 06:50 ET
|
Insys Therapeutics, Inc.
PHOENIX, July 17, 2017 (GLOBE NEWSWIRE) -- Insys Therapeutics, Inc. (NASDAQ:INSY) (“Insys” or “the Company”) issued a statement today on its interactions with payors: Insys, in concert with its...
Insys Therapeutics Hires Four Key Pharmaceutical Industry Veterans for Leadership Positions
June 20, 2017 06:50 ET
|
Insys Therapeutics, Inc.
PHOENIX, June 20, 2017 (GLOBE NEWSWIRE) -- Insys Therapeutics, Inc. (NASDAQ:INSY) (“Insys” or “the Company”) today announced the addition of four pharmaceutical industry veterans to its management...
Insys Therapeutics, Inc. Releases Statement on Its Ongoing Mission
June 05, 2017 06:50 ET
|
Insys Therapeutics, Inc.
PHOENIX, June 05, 2017 (GLOBE NEWSWIRE) -- Insys Therapeutics, Inc. (NASDAQ:INSY) (“Insys” or “the Company”) issued a response to the recent media reports that highlight concerns with the Company’s...
Insys Therapeutics, Inc. to Present at June Conferences
May 31, 2017 06:50 ET
|
Insys Therapeutics, Inc.
PHOENIX, May 31, 2017 (GLOBE NEWSWIRE) -- Insys Therapeutics, Inc. (“Insys” or “the Company”) (NASDAQ:INSY) today announced that Saeed Motahari, President and Chief Executive Officer, and Darryl...
Insys Sponsors Cancer Caregivers Education Program
May 25, 2017 12:00 ET
|
Insys Therapeutics, Inc.
PHOENIX, May 25, 2017 (GLOBE NEWSWIRE) -- Insys Therapeutics, Inc. (“Insys” or “the Company”) today announced its sponsorship of the Arizona Myeloma Network’s (“AzMN”) Cancer Caregivers Education...
Insys Therapeutics, Inc. Announces FDA Final Product Label for Syndros
May 24, 2017 06:50 ET
|
Insys Therapeutics, Inc.
PHOENIX, May 24, 2017 (GLOBE NEWSWIRE) -- Insys Therapeutics, Inc. (NASDAQ:INSY) (“Insys” or “the Company”) today announced that the U.S. Food and Drug Administration (“FDA”) has approved the final...
Insys Therapeutics Announces Chief Financial Officer Transition
May 16, 2017 06:50 ET
|
Insys Therapeutics, Inc.
PHOENIX, May 16, 2017 (GLOBE NEWSWIRE) -- Insys Therapeutics, Inc. (NASDAQ:INSY) ("Insys" or "the Company") today announced that Darryl S. Baker, the Company's Chief Financial Officer (“CFO”), will...
Insys Therapeutics Reports First Quarter 2017 Results
May 09, 2017 06:50 ET
|
Insys Therapeutics, Inc.
PHOENIX, May 09, 2017 (GLOBE NEWSWIRE) -- Insys Therapeutics, Inc. (NASDAQ:INSY) ("Insys" or "the Company") today announced financial results for the three-month period ended March 31, 2017. ...
Insys Therapeutics, Inc. Appoints Rohit Vishnoi to Board of Directors
May 04, 2017 08:45 ET
|
Insys Therapeutics, Inc.
PHOENIX, Ariz., May 04, 2017 (GLOBE NEWSWIRE) -- Insys Therapeutics, Inc. (NASDAQ:INSY) ("Insys" or "the Company") announced that Rohit Vishnoi, a seasoned healthcare executive, has been appointed...
Insys Therapeutics to Report First Quarter 2017 Results on May 9, 2017
April 25, 2017 16:30 ET
|
Insys Therapeutics, Inc.
PHOENIX, April 25, 2017 (GLOBE NEWSWIRE) -- Insys Therapeutics, Inc. (NASDAQ:INSY) (“Insys” or “Company”) today announced that the Company will release its first quarter 2017 financial results on...